XIG: FHIR Resources

FHIR IG Statistics: FHIR Resources

Version: All | R2 | R2B | R3 | R4 | R4B | R5 | R6
Authority: All | hl7 | ihe | national
Realm: All | BNW | au | be | br | ca | ch | cl | cr | cz | de | dk | ee | eu | fi | fr | il | in | it | jp | kr | nl | no | nz | pl | se | sl | stt | tw | uk | us | uv | vn
View: All | Resource Profiles | Datatype Profiles | Extensions | Logical Models | CodeSystems | ValueSets | ConceptMaps

Resources - All Kinds

75,411 resources

By Version

R2: 0
R2B: 0
R3: 3,448
R4: 55,341
R4B: 3,134
R5: 13,264
R6: 224

By Authority

none: 25,640
hl7: 42,405
ihe: 1,382
national: 3,470
who: 2,514

By Realm

none: 22,398
au: 648
be: 387
br: 299
ca: 764
ch: 1,527
cl: 469
cr: 45
cz: 384
de: 2,066
dk: 1,474
ee: 276
eu: 1,253
fi: 87
fr: 1,545
il: 308
in: 163
it: 181
jp: 293
kr: 5
nl: 2,153
no: 26
nz: 79
pl: 83
se: 29
sl: 2
stt: 116
tw: 901
uk: 97
us: 19,481
uv: 17,592
vn: 107
other: 7

Start Prev Rows 49400 - 49600 Next

Package	Version	Identity	Name/Title	Status	Date	Realm	Auth
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2498	Cloacal Exstrophy (Disorders) (SNOMED)	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2499	Cloacal Exstrophy (Disorders) (ICD10CM)	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2500	Renal Agenesis or Hypoplasia (Disorders) (SNOMED)	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2501	Renal Agenesis or Hypoplasia (Disorders) (ICD10CM)	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2502	Trisomy 13 (Disorders) (SNOMED)	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2503	Trisomy 13 (Disorders) (ICD10CM)	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2504	Fetal Trisomy 13 (Disorders) (SNOMED)	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2505	Trisomy 13 (Tests for Trisomy 13 Chromosomal Anomaly)	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2506	Galactosemia (Disorders) (SNOMED)	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2507	Galactosemia (Disorders) (ICD10CM)	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2508	Galactosemia (Tests for Galactose_1_Phosphate Uridyltransferase [Quantitative] in Blood)	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2509	Galactosemia (Tests for Galactokinase (GALK) [Quantitative] in Blood)	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2510	Galactosemia (Tests for UDP_galactose 4' epimerase (GALE) [Quantitative] in Blood)	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2511	Galactosemia (Tests for Galactose_1_Phosphate Uridyltransferase [Quantitative])	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2512	Galactosemia (Tests for Galactokinase (GALK) [Quantitative])	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2513	Galactosemia (Tests for UDP_galactose 4' epimerase (GALE) [Quantitative])	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2514	Galactosemia (Tests for GALT gene allele 1)	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2515	Galactosemia (Tests for GALT gene allele 2)	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2516	Hypospadias (Disorders) (SNOMED)	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2517	Hypospadias (Disorders) (ICD10CM)	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2518	Trisomy 18 (Disorders) (SNOMED)	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2519	Fetal Trisomy 18 (Disorders) (SNOMED)	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2520	Fetal Trisomy 18 (Disorders) (ICD10CM)	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2521	Trisomy 18 (Disorders) (ICD10CM)	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2522	Trisomy 18 (Tests for Trisomy 18 Chromosomal Anomaly)	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2523	Chlamydia trachomatis Infection (Tests for unspecified Chlamydia species by Culture and Identification Method)	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2524	Chlamydia trachomatis Infection (Tests for unspecified Chlamydia species Nucleic Acid)	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2525	Chlamydia trachomatis Infection (Tests for unspecified Chlamydia species Antigen)	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2526	Chlamydia trachomatis Infection (Combination Tests that include Chlamydia trachomatis Nucleic Acid)	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2527	Chlamydia species [Unspecified] (Organism or Substance in Lab Results)	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2528	Ventricular septal defect (Disorders) (SNOMED)	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2529	Ventricular septal defect (Disorders) (ICD10CM)	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2530	Gonorrhea (Combination Tests that include Neisseria Gonorrhea Nucleic Acid)	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2531	Intracellular Gram Negative Diplococcus (Organism or Substance in Lab Results)	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2532	Congenital Cytomegalovirus (Tests for CMV Nucleic Acid)	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.2533	Congenital Cytomegalovirus (Tests for CMV Antibody)	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.268	Mumps (Tests for mumps virus IgM Antibody)	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.272	Present or Positive Lab Result Value	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.282	Varicella (Tests for Varicella zoster virus by Culture and Identification Method)	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.283	Varicella (Tests for Varicella zoster virus Nucleic Acid)	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.285	Encephalitis (Disorders) (ICD10CM)	active	2023-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.287	Varicella (Organism or Substance in Lab Results)	active	2023-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.289	Carbon Monoxide Poisoning (Disorders) (ICD10CM)	active	2023-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.293	Toxic Effects of Lead (Disorders) (ICD10CM)	active	2023-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.297	Measles (Tests for measles virus Nucleic Acid)	active	2025-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.299	Measles (Tests for measles virus IgM Antibody)	active	2025-03	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.300	Meningococcal Disease (Organism or Substance in Lab Results)	active	2023-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.301	Shigellosis (Tests for Shigella species by Culture and Identification Method)	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.307	Leptospirosis (Tests for Leptospira IgM Antibody)	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.308	Invasive Pneumococcal Disease (Tests for Streptococcus pneumoniae Nucleic Acid)	active	2023-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.310	Bacteria (Tests by Culture and Identification Method)	active	2023-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.311	Viruses (Tests by Culture and Identification Method)	active	2023-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.316	Rubella (Tests for rubella virus IgM Antibody)	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.317	Shigellosis (Tests for Shigella species Nucleic Acid)	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.319	Fungi (Tests by Culture and Identification Method)	active	2024-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.322	Pesticide Related Illness (Disorders) (ICD10CM)	active	2023-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.329	Apnea (SNOMED)	active	2024-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.330	Apnea (ICD10CM)	active	2024-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.333	Shigellosis (Organism or Substance in Lab Results)	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.335	Influenza (Tests for influenza A virus by Culture and Identification Method)	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.336	Influenza (Tests for influenza A or B virus Nucleic Acid)	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.340	Influenza (influenza A or B virus in Lab Results)	active	2023-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.341	Campylobacteriosis (Organism or Substance in Lab Results)	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.342	Campylobacteriosis (Tests for Campylobacter species by Culture and Identification Method)	active	2023-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.343	Campylobacteriosis (Tests for Campylobacter species Nucleic Acid)	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.344	Campylobacteriosis (Tests for Campylobacter species Antigen)	active	2023-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.349	Hepatitis A (Tests for hepatitis A virus IgM Antibody)	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.353	Diarrhea (SNOMED)	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.356	HIV Infection (Organism or Substance in Lab Results)	active	2023-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.359	Botulism (Disorders) (SNOMED)	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.362	Hansen’s Disease (Disorders) (SNOMED)	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.365	Silicosis (Disorders) (SNOMED)	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.366	Silicosis (Disorders) (ICD10CM)	active	2023-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.371	Cryptosporidiosis (Organism or Substance in Lab Results)	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.372	Cryptosporidiosis (Tests for Cryptosporidium species Nucleic Acid)	active	2023-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.375	Cyclosporiasis (Organism or Substance in Lab Results)	active	2023-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.376	Cyclosporiasis (Tests for Cyclospora cayetanensis Nucleic Acid)	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.379	Giardiasis (Tests for Giardia species Nucleic Acid)	active	2023-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.384	Listeriosis (Tests for Listeria monocytogenes Nucleic Acid)	active	2024-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.386	Vibriosis (Organism or Substance in Lab Results)	active	2024-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.388	Vibriosis (Tests for Vibrionaceae species [except Toxigenic Vibrio cholera O1 and O139] Nucleic Acid)	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.390	Trichinellosis (Tests for Trichinella species Antibody)	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.395	Syphilis (Disorders) (SNOMED)	active	2024-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.396	Syphilis (Disorders) (ICD10CM)	active	2023-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.398	Hepatitis C Virus Infection (Tests for hepatitis C virus Nucleic Acid)	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.399	Hepatitis C Virus Infection (Tests for hepatitis C virus Antigen)	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.40	STEC Infection (Disorders) (SNOMED)	active	2023-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.400	Hepatitis B Virus Infection (Tests for hepatitis B virus IgM Antibody)	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.401	Hepatitis B Virus Infection (Tests for hepatitis B virus surface Antigen)	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.403	Hepatitis B Virus Infection (Tests for hepatitis B virus Nucleic Acid)	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.405	Hantavirus Infection and Diseases (Disorders) (ICD10CM)	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.407	Hepatitis C Virus Infection (Tests for hepatitis C virus Antibody)	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.408	Hepatitis B Virus Infection (Organism or Substance in Lab Results)	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.422	Tuberculosis (Disorders) (SNOMED)	active	2023-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.427	STEC Infection (Tests for Shiga toxin genes, or STEC, EHEC, or E. coli O157 Nucleic Acid)	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.43	Gonorrhea [Cervicitis Urethritis] (Disorders) (SNOMED)	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.436	Coccidioidomycosis (Tests for Coccidioides species IgM Antibody)	active	2024-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.437	Coccidioidomycosis (Tests for Coccidioides species Nucleic Acid)	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.438	Coccidioidomycosis (Tests for Coccidioides species Antigen)	active	2024-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.44	Gonorrhea [Cervicitis Urethritis] (Disorders) (ICD10CM)	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.445	Legionellosis (Tests for Legionella species Antigen)	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.446	Legionellosis (Tests for Legionella species Nucleic Acid)	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.451	Tuberculosis (Disorders) (ICD10CM)	active	2023-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.460	HIV Infection or AIDS (Disorders) (SNOMED)	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.464	Malaria (Tests for Plasmodium species Nucleic Acid)	active	2023-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.468	Leptospirosis (Tests for Leptospira Nucleic Acid)	active	2024-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.471	Leptospirosis (Tests for Leptospira Antibody [Quantitative] by Agglutination)	active	2023-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.472	Leptospirosis (Tests for Leptospira Antibody)	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.476	Babesia species (Tests by Microscopic Observation in Blood)	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.478	Anthrax (Tests for Bacillus anthracis by Culture and Identification Method)	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.479	Anthrax (Tests for Bacillus anthracis Nucleic Acid)	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.48	Salmonellosis (Disorders) (SNOMED)	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.480	Anthrax (Tests for Bacillus anthracis Antigen)	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.481	Anthrax (Tests for Bacillus anthracis Antibody)	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.494	Ehrlichiosis (Organism or Substance in Lab Results)	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.496	Q Fever (Tests for Coxiella burnetii IgM IgG Antibody [Excluding Quantitative IFA Tests for IgG Antibody against Phase I or II Antigen])	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.500	Q Fever (Tests for Coxiella burnetii Nucleic Acid)	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.505	Toxic Shock Syndrome (TSS) (Disorders) (SNOMED)	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.507	Toxic Shock Syndrome (TSS) (Disorders) (ICD10CM)	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.512	Brucellosis (Tests for Brucella species Nucleic Acid)	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.515	Brucellosis (Tests for Brucella species Antibody [Quantitative])	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.516	Brucellosis (Organism or Substance in Lab Results)	active	2024-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.519	Dengue Virus Infection (Tests for dengue virus Nucleic Acid)	active	2024-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.523	Dengue Virus Infection (Tests for dengue virus Antigen)	active	2024-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.524	Dengue Virus Infection (Tests for dengue virus IgG or Total Antibody [Quantitative])	active	2023-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.525	Dengue Virus Infection (Tests for dengue virus IgM Antibody)	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.527	Dengue Virus Infection (Tests for dengue virus IgG or Total Antibody [Qualitative])	active	2023-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.530	Borrelia species (Tests for Nucleic Acid)	active	2024-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.531	Lyme Disease (Tests for Borrelia burgdorferi IgM IgG Antibody by Immunoblot)	active	2024-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.532	Lyme Disease (Tests for Borrelia burgdorferi Antibody by Immunoassay)	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.534	Smallpox (Organism or Substance in Lab Results)	active	2023-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.548	St. Louis Encephalitis Virus Infection (Tests for Saint Louis encephalitis virus Antibody [Qualitative])	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.550	Syphilis (Tests for Treponema pallidum Nucleic Acid)	active	2024-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.553	Anaplasma species (Tests by Microscopic Observation)	active	2023-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.555	Yellow Fever (Tests for yellow fever virus Nucleic Acid)	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.557	Yellow Fever (Tests for yellow fever virus Antibody [Quantitative])	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.56	Diarrhea (ICD10CM)	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.560	West Nile Virus Infection (Tests for West Nile virus Nucleic Acid)	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.569	Plague (Tests for Yersinia pestis Nucleic Acid)	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.58	Pertussis (Tests for Bordetella pertussis Nucleic Acid)	active	2023-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.595	Tularemia (Tests for Francisella tularensis Nucleic Acid)	active	2023-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.598	Tularemia (Tests for Francisella tularensis Antibody)	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.6	Diphtheria (Disorders) (SNOMED)	active	2023-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.605	Organisms (Tests by Microscopic Observation by Acid Fast Stain)	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.606	Tuberculosis (Organism or Substance in Lab Results)	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.614	Pertussis (Tests for Bordetella pertussis Toxin Antibody)	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.621	Inspiratory Whoop (ICD10CM)	active	2023-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.632	Chlamydia trachomatis Infection [Secondary Sites Complications] (Disorders) (SNOMED)	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.645	Pertussis (Test Panels for Bordetella pertussis and Bordetella parapertussis Nucleic Acid)	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.648	Vomiting (ICD10CM)	active	2023-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.650	Jaundice (SNOMED)	active	2023-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.652	Bacteria (Tests in Specimen from Normally Sterile Site by Culture and Identification Method)	active	2024-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.660	Hypertonia [Excluding Congenital Hypertonia] (SNOMED)	active	2024-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.662	Chest Pain (ICD10CM)	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.663	Erythema Nodosum (SNOMED)	active	2024-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.664	Congenital Zika Syndromes (SNOMED)	active	2024-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.665	Congenital Zika Syndromes (ICD10CM)	active	2023-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.666	Guillain Barré syndrome (Disorders) (SNOMED)	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.668	Rash (SNOMED)	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.671	Fever (ICD10CM)	active	2023-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.672	Arthralgia (SNOMED)	active	2023-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.673	Arthralgia (ICD10CM)	active	2023-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.674	Conjunctivitis (SNOMED)	active	2024-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.675	Conjunctivitis (ICD10CM)	active	2023-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.676	Pregnant (SNOMED)	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.677	Postpartum (SNOMED)	active	2024-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.678	Postpartum (ICD10CM)	active	2023-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.679	Hearing Loss (SNOMED)	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.680	Abdominal Pain (ICD10CM)	active	2023-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.681	Abdominal Pain (SNOMED)	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.686	Erythema Multiforme (SNOMED)	active	2023-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.687	Myalgia (ICD10CM)	active	2023-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.689	Periorbital Edema (ICD10CM)	active	2023-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.691	Eosinophilia (ICD10CM)	active	2023-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.692	Eosinophilia (SNOMED)	active	2023-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.70	Salmonellosis (Tests for Salmonella except S. typhi and S. paratyphi by Culture and Identification Method)	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.702	Weight Loss (SNOMED)	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.705	Syphilis (Tests for Treponemal or Non Treponemal Antibody)	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.709	Cough [Non Productive] (SNOMED)	active	2023-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.71	Salmonellosis (Tests for Salmonella except S. typhi and S. paratyphi Nucleic Acid)	active	2024-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.711	Wound Infection (SNOMED)	active	2024-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.712	Pneumonia (ICD10CM)	active	2024-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.713	Sepsis [Septicemia] [Unspecified Organism] (ICD10CM)	active	2023-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.714	Sepsis [Septicemia] [Unspecified Organism] (SNOMED)	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.715	Meningitis (SNOMED)	active	2023-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.717	Cellulitis (ICD10CM)	active	2023-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.718	Cellulitis (SNOMED)	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.719	Myositis [Unspecified Cause] (SNOMED)	active	2023-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.720	Myositis [Unspecified Cause] (ICD10CM)	active	2023-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.721	Otitis Media (SNOMED)	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.722	Otitis Media (ICD10CM)	active	2023-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.723	Otitis Externa (SNOMED)	active	2025-02	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.724	Otitis Externa (ICD10CM)	active	2023-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.727	Acute Upper Respiratory Illness (SNOMED)	active	2023-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.728	HIV Infection (Tests for HIV Nucleic Acid [Qualitative])	active	2023-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.730	HIV Infection (Tests for HIV Antibody)	active	2023-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.733	Perinatal Hepatitis B Virus Infection (Disorders) (SNOMED)	active	2023-06	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.744	Coccidioidomycosis (Tests for Coccidioides species IgG Antibody)	active	2024-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.746	Treponema pallidum (Tests by Microscopic Observation)	active	2022-01	us	hl7
us.nlm.vsac	R4	ValueSet/2.16.840.1.113762.1.4.1146.750	Chest Pain (SNOMED)	active	2024-06	us	hl7